Gut microbiota and the development of obesity;La microbiota intestinal y el desarrollo de la obesidad

Nutricion Hospitalaria

Volumn 27, Issue 5, 2012, Pages 1408-1414

  Boroni Moreira, A P ^a   Fiche Salles Teixeira, T ^a   do Gouveia Peluzio, C ^a   de Cassia Goncalves Alfenas R ^a  

^a FEDERAL UNIVERSITY OF VIÇOSA   (Brazil)

Author keywords

Endocannabinoid system; Gut microbiota; Inflammation; Intestinal permeability; Obesity

Indexed keywords

ANIMAL; BODY COMPOSITION; GASTROINTESTINAL TRACT; HUMAN; METABOLIC DISORDER; MICROBIOLOGY; MICROFLORA; OBESITY; PHYSIOLOGY;

ANIMALS; BODY COMPOSITION; GASTROINTESTINAL TRACT; HUMANS; METABOLIC DISEASES; MICROBIOTA; OBESITY;

EID: 84867483542     PISSN: 02121611     EISSN: 16995198     Source Type: Journal    
DOI: 10.3305/nh.2012.27.5.5887     Document Type: Review

References (55)

1. Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 2011; 10 (Suppl. 1): S10.
2. Vrieze A, Holleman F, Zoetendal EG, de Vos WM, Hoekstra JBL, Nieuwdorp M. The environment within: how gut microbiota may influence metabolism and body composition. Diabetologia 2010; 53 (4): 606-613.
3. Murphy EF, Cotter PD, Healy S, Marques TM, O'Sullivan, Fouhy F et al. Composition and energy harvesting capacity of the gut microbiota: relationship to diet, obesity and time in mouse models. Gut 2010; 59 (12): 1635-1642.
4. Kootte RS, Vrieze A, Holleman F, Dallinga-Thie GM, Zoetendal EG, de Vos WM et al. The therapeutic potential of manipulating gut microbiota in obesity and type 2 diabetes mellitus. Diabetes Obes Metab 2012; 14 (2): 112-120.
5. Palmer C, Bik EM, DiGiulio DB, Relman DA, Brown PO. Development of the human infant intestinal microbiota. PLoS Biol 2007; 5 (7): e177.
6. Frazier TH, DiBiase JK, McClain CJ. Gut Microbiota, intestinal permeability, obesity-induced inflammation, and liver injury. J Parenter Enteral Nutr 2011; 35 (5 Suppl.): 14S-20S.
7. Sekirov I, Russell SL, Antunes LC, Finlay BB. Gut microbiota in health and disease. Physiol Rev 2010; 90 (3): 859-904.
8. Montalto M, D'Onofrio F, Gallo A, Cazzato A, Gasbarrini G. Intestinal microbiota and its functions. Dig Liver Dis 2009; 3 (2): 30-34.
9. Stappenbeck TS, Hooper LV, Gordon JI. Developmental regulation of intestinal angiogenesis by indigenous microbes via Paneth cells. Proc Natl Acad Sci USA 2002; 99 (24): 15451-15455.
10. Qin J, Li R, Raes J, Arumugam M, Burgdorf KS, Manichanh C et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010; 464 (7285): 59-65.
11. Hattori M, Taylor TD. The human intestinal microbiome: a new frontier of human biology. DNA Res 2009; 16 (1): 1-12.
12. Turnbaugh PJ, Hamady M, Yatsunenko T, Cantarel BL, Duncan A, Ley RE et al. A core gut microbiome in obese and lean twins. Nature 2009; 457 (7228): 480-484.
13. Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mards ER, Gordon JI. An obesity-associated gut microbiome with increased capacity for energy harvest. Nature 2006; 444 (7122): 1027-1031.
14. Lyra A, Lahtinen S, Tiihonen K, Ouwehand AC. Intestinal microbiota and overweight. Benef Microbes 2010; 1 (4): 407-421.
15. Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity alters gut microbial ecology. Proc Natl Acad Sci USA 2005; 102 (31): 11070-11075.
16. Backhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A et al. The gut microbiota as an environmental factor that regulates fat storage. Proc Natl Acad Sci USA 2004; 101 (44): 15718-15723.
17. Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Microbial ecology: human gut microbes associated with obesity. Nature 2006; 444 (7122): 1022-1023.
18. Schwiertz A, Taras D, Schafer K, Beijer S, Bos NA, Donus C et al. Microbiota and SCFA in lean and overweight healthy subjects. Obesity 2010; 18 (1): 190-195.
19. Delzenne NM, Neyrinck AM, Cani PD. Modulation of the gut microbiota by nutrients with prebiotic properties: consequences for host health in the context of obesity and metabolic syndrome. Microb Cell Fact 2011; 10 (Suppl. 1): S10.
20. Blaut M, Klaus S. Intestinal microbiota and obesity. Handb Exp Pharmacol 2012; 209: 251-273.
21. Samuel BS, Shaito A, Motoike T, Rey FE, Backhed F, Manchester JK et al. Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci USA 2008; 105 (43): 16767-16772.
22. Musso G, Gambino R, Cassader M. Interactions between gut microbiota and host metabolism predisposing to obesity and diabetes. Annu Rev Med 2011; 62: 361-380.
23. Delzenne NM, Cani PD. Gut microbiota and the pathogenesis of insulin resistance. Curr Diab Rep 2011; 11 (3): 154-159.
24. Ibrügger S, Kristensen M, Mikkelsen MS, Astrup A. Flaxseed dietary fiber supplements for suppression of appetite and food intake. Appetite 2012; 58 (2): 490-495.
25. Mathern JR, Raatz SK, Thomas W, Slavin JL. Effect of fenugreek fiber on satiety, blood glucose and insulin response and energy intake in obese subjects. Phytother Res 2009; 23 (11): 1543-1548.
26. Cani PD, Joly E, Horsmans Y, Delzenne NM. Oligofructose promotes satiety in healthy human: a pilot study. Eur J Clin Nutr 2006; 60 (5): 567-572.
27. Fleissner CK, Huebel N, El-Bary MMA, Loh G, Klaus S, Blaut M. Absence of intestinal microbiota does not protect mice from diet-induced obesity. Br J Nutr 2010; 104 (6): 919-929.
28. Guilherme A, Virbasius JV, Puri V, Czech MP. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 2008; 9 (5): 367-377.
29. Kohen VL, Candela CG, Fernández CF, Rosa LZ, Milla SP, Urbieta M et al. Parámetros hormonales e inflamatorios en un grupo de mujeres con sobrepeso/obesidad. Nutr Hosp 2011; 26 (4): 884-889.
30. Caesar R, Fåk F, Bäckhed F. Effects of gut microbiota on obesity and atherosclerosis via modulation of inflammation and lipid metabolism. J Intern Med 2010; 268 (4): 320-328.
31. Manco M, Putignani L, Bottazzo GF. Gut microbiota, lipopolysaccharides, and innate immunity in the pathogenesis of obesity and cardiovascular risk. Endocr Rev 2010; 31 (6): 817-844.
32. Moreira APB, Alfenas RCG. The influence of endotoxemia on the molecular mechanisms of insulin resistance. Nutr Hosp 2012; 27 (2): 382-390.
33. Cani PD, Delzenne NM. The gut microbiome as therapeutic target. Pharmacol Ther 2011; 130 (2): 202-212.
34. Fujishiro M, Gotoh Y, Katagiri H, Sakoda H, Ogihara T, Anai M et al. Three mitogen-activated protein kinases inhibit insulin signaling by different mechanisms in 3T3-L1 adipocytes. Mol Endocrinol 2003; 17 (3): 487-487.
35. Wang Q, Dziarski R, Kirschning CJ, Muzio M, Gupta D. Micrococci and peptidoglycan activate TLR2 MyD88 IRAK TRAF NIK IKK NF-B signal transduction pathway that induces transcription of interleukin-8. Infect Immun 2001; 69 (4): 2270-2276.
36. Laugerette F, Vors C, Peretti N, Michalski MC. Complex links between dietary lipids, endogenous endotoxins and metabolic inflammation. Biochimie 2011; 93 (1): 39-45.
37. Ghanim H, Sia CL, Upadhyay M, Korzeniewski K, Viswanathan P, Abuaysheh S et al. Orange juice neutralizes the proinflammatory effect of a high-fat, high-carbohydrate meal and prevents endotoxin increase and toll-like receptor expression. Am J Clin Nutr 2010; 91 (4): 940-949.
38. Erridge C, Attina T, Spickett CM, Webb DJ. A high-fat meal induces low-grade endotoxemia: evidence of a novel mechanism of postprandial inflammation. Am J Clin Nutr 2007; 86 (5): 1286-1292.
39. Cani PD, Bibiloni R, Knauf C, Waget A, Neyrinck AM, Delzenne NM et al. Changes in gut microbiota control metabolic endotoxemia-induced inflammation in high-fat dietinduced obesity and diabetes in mice. Diabetes 2008; 57 (6): 1470-1481.
40. Ewaschuk JB, Diaz H, Meddings L, Diederichs B, Dmytrash A, Backer J et al. Secreted bioactive factors from Bifidobacterium infantis enhance epithelial cell barrier function. Am J Physiol Gastrointest Liver Physiol 2008; 295 (5): G1025-G1034.
41. Muccioli GG, Naslain D, Backhed F, Reigstad CS, Lambert DM, Delzenne NM, Cani PD. The endocannabinoid system links gut microbiota to adipogenesis. Mol Syst Biol 2010; 6: 392.
42. Geurts L, Lazarevic V, Derrien M, Everard A, Roye MV, Knauf C et al. Altered gut microbiota and endocannabinoid system tone in obese and diabetic leptin-resistant mice: impact on apelin regulation in adipose tissue. Front Microbiol 2011; 2: 149.
43. Cluny NL, Reimer RA, Sharkev KA. Cannabinoid signaling regulates inflammation and energy balance: The importance of the brain-gut axis. Brain Behav Immun, 2012 (In the Press).
44. Cani P, Neyrinck A, Fava F, Knauf C, Burcelin R, Tuohy K et al. Selective increases of bifidobacteria in gut microflora improve high-fat-diet-induced diabetes in mice through a mechanism associated with endotoxaemia. Diabetologia 2007; 50 (11): 2374-2383.
45. Moreira APB, Teixeira TFS, Ferreira AB, Peluzio MCG, Alfenas RCG. Influence of a high-fat diet on gut microbiota, intestinal permeability and metabolic endotoxaemia. Br J Nutr 2012 (In the Press).
46. De Bandt JP, Waligora-Dupriet AJ, Butel MJ. Intestinal microbiota in inflammation and insulin resistance: relevance to humans. Curr Opin Clin Nutr Metab Care 2011; 14 (4): 334-340.
47. Diamant M, Blaak EE, de Vos WM. Do nutrient-gut-microbiota interactions play a role in human obesity, insulin resistance and type 2 diabetes? Obes Rev 2011; 12 (4): 272-2781.
48. Tiihonen K, Ouwehand AC, Rautonen N. Effect of overweight on gastrointestinal microbiology and immunology: correlation with blood biomarkers. Br J Nutr 2010; 103 (7): 1070-1078.
49. Phillips ML. Gut reaction: environmental effects on the human microbiota. Environ Health Perspect 2009; 117 (5): A198-A205.
50. Waitzberg DL, Pereira CCA, Logullo L, Jacintho TM, Almeida D, Silva MLT et al. Microbiota benefits after inulin and partially hydrolized guar gum supplementation - a randomized clinical trial in constipated women. Nutr Hosp 2012; 27 (1): 123-129.
51. Li JV, Ashrafian H, Bueter M, Kinross J, Sands C, le Roux CW et al. Metabolic surgery profoundly influences gut microbial- host metabolic cross-talk. Gut 2011; 60 (9): 1214-1223.
52. Romeo J, Nova E, Wärnberg J, Gómez-Martínez S, Ligia LED, Marcos A. Immunomodulatory effect of fibres, probiotics and synbiotics in different life-stages. Nutr Hosp 2010; 25 (3): 341-349.
53. Cani PD, Possemiers S, van de Wiele T, Guiot Y, Everard A, Rottier O et al. Changes in gut microbiota control inflammation in obese mice through a mechanism involving GLP-2-driven improvement of gut permeability. Gut 2009; 58 (8): 1091-1103.
54. Vijay-Kumar M, Aitken JD, Carvalho FA, Cullender TC, Mwangi S, Srinivasan S et al. Metabolic syndrome and altered gut microbiota in mice lacking Toll-like receptor 5. Science 2010; 328 (5975): 228-231.
55. Takemura N, Okubo T, Sonoyama K. Lactobacillus plantarum strain No. 14 reduces adipocyte size in mice fed high-fat diet. Exp Biol Med 2010; 235 (7): 849-856.